Analyses TodayMorningstar's Fair Value sp still is piercing $1.00, sitting at $1.06 this morning. As expected there appears to have been a recording error (by 1 decimal point) as the 1-star valuation is at $8.79. Further to that is an update on the importance of the 1-star valuation. It is defined, by Morningstar, as the sp above which the stock would be significantly overvalued. That's an impressive number!
Barchart has slipped a little to a 16% BUY while the resistance levels are at $.43, $.45 and $.48. The strongest level of support is at $.38.
While time is becoming ever more important the scale to which testing has reached suggests any approval for AcuVid provided in the next three weeks or should see THRM smack in the middle of an extraordinary opportunity. The sooner the better though!!!